{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:28:58Z","timestamp":1772119738689,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T00:00:00Z","timestamp":1728000000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T00:00:00Z","timestamp":1728000000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s11060-024-04834-9","type":"journal-article","created":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T11:02:01Z","timestamp":1728039721000},"page":"65-73","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Predictors of brain metastases in patients with oligometastatic solid tumours treated with stereotactic body radiation therapy"],"prefix":"10.1007","volume":"171","author":[{"given":"Kevin Yijun","family":"Fan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna Joanna","family":"Jerzak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sudhir","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronika","family":"Moravan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Badr","family":"Id Said","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunit","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander V.","family":"Louie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hany","family":"Soliman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arjun","family":"Sahgal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanbo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,10,4]]},"reference":[{"issue":"1","key":"4834_CR1","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1200\/JCO.1995.13.1.8","volume":"13","author":"S Hellman","year":"1995","unstructured":"Hellman S, Weichselbaum RR, Oligometastases (1995) J Clin Oncol off J Am Soc Clin Oncol 13(1):8\u201310","journal-title":"J Clin Oncol off J Am Soc Clin Oncol"},{"issue":"1","key":"4834_CR2","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/s41416-020-01128-5","volume":"124","author":"TH Beckham","year":"2021","unstructured":"Beckham TH, Yang TJ, Gomez D, Tsai CJ (2021) Metastasis-directed therapy for oligometastasis and beyond. Br J Cancer 124(1):136\u2013141","journal-title":"Br J Cancer"},{"issue":"1","key":"4834_CR3","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1016\/S1470-2045(19)30718-1","volume":"21","author":"M Guckenberger","year":"2020","unstructured":"Guckenberger M, Lievens Y, Bouma AB, Collette L, Dekker A, deSouza NM et al (2020) Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation. Lancet Oncol 21(1):e18\u201328","journal-title":"Lancet Oncol"},{"issue":"25","key":"4834_CR4","doi-asserted-by":"publisher","first-page":"2830","DOI":"10.1200\/JCO.20.00818","volume":"38","author":"DA Palma","year":"2020","unstructured":"Palma DA, Olson R, Harrow S, Gaede S, Louie AV, Haasbeek C et al (2020) Stereotactic ablative radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: long-term results of the SABR-COMET phase II randomized trial. J Clin Oncol 38(25):2830\u20132838","journal-title":"J Clin Oncol"},{"issue":"18","key":"4834_CR5","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1200\/JCO.19.00201","volume":"37","author":"DR Gomez","year":"2019","unstructured":"Gomez DR, Tang C, Zhang J, Blumenschein GR, Hernandez M, Lee JJ et al (2019) Local consolidative therapy Vs. maintenance Therapy or Observation for patients with Oligometastatic non\u2013small-cell Lung Cancer: long-term results of a multi-institutional, phase II, Randomized Study. J Clin Oncol 37(18):1558\u20131565","journal-title":"J Clin Oncol"},{"issue":"1","key":"4834_CR6","doi-asserted-by":"publisher","first-page":"e173501","DOI":"10.1001\/jamaoncol.2017.3501","volume":"4","author":"P Iyengar","year":"2018","unstructured":"Iyengar P, Wardak Z, Gerber DE, Tumati V, Ahn C, Hughes RS et al (2018) Consolidative Radiotherapy for Limited Metastatic non\u2013small-cell lung Cancer: a phase 2 Randomized Clinical Trial. JAMA Oncol 4(1):e173501","journal-title":"JAMA Oncol"},{"issue":"14","key":"4834_CR7","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1200\/JCO.2004.12.149","volume":"22","author":"JS Barnholtz-Sloan","year":"2004","unstructured":"Barnholtz-Sloan JS, Sloan AE, Davis FG, Vigneau FD, Lai P, Sawaya RE (2004) Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System. J Clin Oncol off J Am Soc Clin Oncol 22(14):2865\u20132872","journal-title":"J Clin Oncol off J Am Soc Clin Oncol"},{"key":"4834_CR8","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3389\/fonc.2019.00206","volume":"9","author":"R Mazzola","year":"2019","unstructured":"Mazzola R, Corradini S, Gregucci F, Figlia V, Fiorentino A, Alongi F (2019) Role of Radiosurgery\/Stereotactic Radiotherapy in Oligometastatic Disease: Brain oligometastases. Front Oncol 9:206","journal-title":"Front Oncol"},{"issue":"1","key":"4834_CR9","first-page":"15","volume":"27","author":"M Lupattelli","year":"2022","unstructured":"Lupattelli M, Tini P, Nardone V, Aristei C, Borghesi S, Maranzano E et al (2022) Stereotactic radiotherapy for brain oligometastases. Rep Pract Oncol Radiother J Gt Cancer Cent Poznan Pol Soc Radiat Oncol 27(1):15\u201322","journal-title":"Rep Pract Oncol Radiother J Gt Cancer Cent Poznan Pol Soc Radiat Oncol"},{"issue":"11","key":"4834_CR10","first-page":"e31197","volume":"14","author":"JO AlTamimi","year":"2022","unstructured":"AlTamimi JO, AlJohani HA, Naaman N, Johar RA, Allam TA, Lary DAI (2022) Brain metastases in adults: a five-year observational study from King Abdulaziz Medical City. Cureus 14(11):e31197","journal-title":"Cureus"},{"issue":"3","key":"4834_CR11","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1093\/neuonc\/noab285","volume":"24","author":"N Lamba","year":"2022","unstructured":"Lamba N, Catalano PJ, Bi WL, Wen PY, Haas-Kogan DA, Cagney DN et al (2022) Predictors of long-term survival among patients with brain metastases. Neuro-Oncol 24(3):494\u2013496","journal-title":"Neuro-Oncol"},{"key":"4834_CR12","doi-asserted-by":"crossref","unstructured":"Nieder C, Haukland E, Manns\u00e5ker B, Pawinski AR, Yobuta R, Dalhaug A Presence of Brain Metastases at Initial Diagnosis of Cancer: Patient Characteristics and Outcome. Cureus [Internet]. 2019 Feb 21 [cited 2024 Jan 6]; https:\/\/www.cureus.com\/articles\/16541-presence-of-brain-metastases-at-initial-diagnosis-of-cancer-patient-characteristics-and-outcome","DOI":"10.7759\/cureus.4113"},{"issue":"32","key":"4834_CR13","doi-asserted-by":"publisher","first-page":"3773","DOI":"10.1200\/JCO.20.01255","volume":"38","author":"PW Sperduto","year":"2020","unstructured":"Sperduto PW, Mesko S, Li J, Cagney D, Aizer A, Lin NU et al (2020) Survival in patients with brain metastases: Summary Report on the updated diagnosis-specific graded Prognostic Assessment and Definition of the eligibility quotient. J Clin Oncol 38(32):3773\u20133784","journal-title":"J Clin Oncol"},{"issue":"11","key":"4834_CR14","doi-asserted-by":"publisher","first-page":"e2026312","DOI":"10.1001\/jamanetworkopen.2020.26312","volume":"3","author":"I Poon","year":"2020","unstructured":"Poon I, Erler D, Dagan R, Redmond KJ, Foote M, Badellino S et al (2020) Evaluation of definitive stereotactic body radiotherapy and outcomes in adults with Extracranial Oligometastasis. JAMA Netw Open 3(11):e2026312","journal-title":"JAMA Netw Open"},{"issue":"12","key":"4834_CR15","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.2217\/fon-2016-0479","volume":"13","author":"KJ Redmond","year":"2017","unstructured":"Redmond KJ, Lo SS, Dagan R, Poon I, Foote MC, Erler D et al (2017) A multinational report of technical factors on stereotactic body radiotherapy for oligometastases. Future Oncol Lond Engl 13(12):1081\u20131089","journal-title":"Future Oncol Lond Engl"},{"key":"4834_CR16","unstructured":"R Foundation for Statistical Computing. R: A Language and Environment for Statistical ## Computing [Internet]. Vienna, Austria (2023) https:\/\/www.R-project.org\/"},{"issue":"2","key":"4834_CR17","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/j.1552-6569.2012.00767.x","volume":"24","author":"V Hatzoglou","year":"2014","unstructured":"Hatzoglou V, Patel GV, Morris MJ, Curtis K, Zhang Z, Shi W et al (2014) Brain metastases from prostate cancer: an 11-year analysis in the MRI era with emphasis on imaging characteristics, incidence, and prognosis. J Neuroimaging off J Am Soc Neuroimaging 24(2):161\u2013166","journal-title":"J Neuroimaging off J Am Soc Neuroimaging"},{"issue":"6","key":"4834_CR18","doi-asserted-by":"publisher","first-page":"650","DOI":"10.18632\/oncotarget.27453","volume":"11","author":"L Koniali","year":"2020","unstructured":"Koniali L, Hadjisavvas A, Constantinidou A, Christodoulou K, Christou Y, Demetriou C et al (2020) Risk factors for breast cancer brain metastases: a systematic review. Oncotarget 11(6):650\u2013669","journal-title":"Oncotarget"},{"key":"4834_CR19","doi-asserted-by":"publisher","first-page":"1092721","DOI":"10.3389\/fonc.2023.1092721","volume":"13","author":"B Wu","year":"2023","unstructured":"Wu B, Zhou Y, Yang Y, Zhou D (2023) Risk factors and a new nomogram for predicting brain metastasis from lung cancer: a retrospective study. Front Oncol 13:1092721","journal-title":"Front Oncol"},{"issue":"13","key":"4834_CR20","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1200\/JCO.19.01508","volume":"38","author":"LE Haydu","year":"2020","unstructured":"Haydu LE, Lo SN, McQuade JL, Amaria RN, Wargo J, Ross MI et al (2020) Cumulative incidence and predictors of CNS Metastasis for Patients with American Joint Committee on Cancer 8th Edition Stage III Melanoma. J Clin Oncol off J Am Soc Clin Oncol 38(13):1429\u20131441","journal-title":"J Clin Oncol off J Am Soc Clin Oncol"},{"key":"4834_CR21","doi-asserted-by":"crossref","unstructured":"Christ SM, Thiel GW, Heesen P, Mayinger M, Willmann J, Ahmadsei M et al Influence of brain metastases on the classification, treatment, and outcome of patients with extracranial oligometastasis: A single-center cross-sectional analysis [Internet]. 2024 [cited 2024 Jul 26]. https:\/\/www.researchsquare.com\/article\/rs-4559627\/v1","DOI":"10.21203\/rs.3.rs-4559627\/v1"},{"issue":"12","key":"4834_CR22","doi-asserted-by":"publisher","first-page":"10230","DOI":"10.3390\/ijms241210230","volume":"24","author":"A Chidharla","year":"2023","unstructured":"Chidharla A, Rapoport E, Agarwal K, Madala S, Linares B, Sun W et al (2023) Circulating tumor DNA as a minimal residual Disease Assessment and recurrence risk in patients undergoing curative-intent resection with or without adjuvant chemotherapy in Colorectal Cancer: a systematic review and Meta-analysis. Int J Mol Sci 24(12):10230","journal-title":"Int J Mol Sci"},{"issue":"2","key":"4834_CR23","doi-asserted-by":"publisher","first-page":"e230475","DOI":"10.1001\/jamanetworkopen.2023.0475","volume":"6","author":"AY Li","year":"2023","unstructured":"Li AY, Gaebe K, Zulfiqar A, Lee G, Jerzak KJ, Sahgal A et al (2023) Association of Brain Metastases with Survival in patients with Limited or stable Extracranial Disease: a systematic review and Meta-analysis. JAMA Netw Open 6(2):e230475","journal-title":"JAMA Netw Open"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-024-04834-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-024-04834-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-024-04834-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T12:03:14Z","timestamp":1735560194000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-024-04834-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,4]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["4834"],"URL":"https:\/\/doi.org\/10.1007\/s11060-024-04834-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4850268\/v1","asserted-by":"object"}]},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,4]]},"assertion":[{"value":"2 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval was obtained from the Sunnybrook Research Institute (REB SUN-5942). This study was performed in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"KJJ serves as a consultant and advisory board member for: Amgen, Astra-Zeneca, Apo Biologix, Eli Lilly, Esai, Genomic Health, Gilead Sciences, Knight Therapeutics, Merck, Myriad Genetics Inc, Pfizer, Roche, Seagen, Novartis, and Viatris. HC has received speaker\u2019s honoraria from Novartis. These organizations had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results. No competing interests from other authors of this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}